Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332

Watchlist Manager
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd Logo
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Watchlist
Price: 29.8 CNY 0.51%
Market Cap: 47.9B CNY
Have any thoughts about
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd?
Write Note

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Revenue

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
Revenue Peer Comparison

Comparables:
H
3692
600436
600276
000538
S
688506

Competitive Revenue Analysis
Latest Figures & CAGR of Competitors

Company Revenue CAGR 3Y CAGR 5Y CAGR 10Y
Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd
SSE:600332
Revenue
ÂĄ76.6B
CAGR 3-Years
4%
CAGR 5-Years
5%
CAGR 10-Years
16%
H
Hansoh Pharmaceutical Group Company Ltd
HKEX:3692
Revenue
ÂĄ10.1B
CAGR 3-Years
5%
CAGR 5-Years
6%
CAGR 10-Years
N/A
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
SSE:600436
Revenue
ÂĄ10.7B
CAGR 3-Years
14%
CAGR 5-Years
15%
CAGR 10-Years
22%
Jiangsu Hengrui Pharmaceuticals Co Ltd
SSE:600276
Revenue
ÂĄ25.3B
CAGR 3-Years
-5%
CAGR 5-Years
5%
CAGR 10-Years
14%
Yunnan Baiyao Group Co Ltd
SZSE:000538
Revenue
ÂĄ39.3B
CAGR 3-Years
3%
CAGR 5-Years
7%
CAGR 10-Years
9%
S
Sichuan Biokin Pharmaceutical Co Ltd
SSE:688506
Revenue
ÂĄ561.9m
CAGR 3-Years
-18%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Revenue?
Revenue
76.6B CNY

Based on the financial report for Jun 30, 2024, Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Revenue amounts to 76.6B CNY.

What is Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd's Revenue growth rate?
Revenue CAGR 10Y
16%

Over the last year, the Revenue growth was 4%. The average annual Revenue growth rates for Guangzhou Baiyunshan Pharmaceutical Holdings Co Ltd have been 4% over the past three years , 5% over the past five years , and 16% over the past ten years .

Back to Top